Oppenheimer said it remains "positive on equities," even amid ongoing trade tensions and tariff uncertainties. Read more here ...

Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly ...

As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...

Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...

Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...

The women filed the lawsuit last Friday against the Milwaukee Bucks, former Bucks guard Patrick Beverley and assistant coach ...

Oppenheimer upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a market perform rating to an outperform rating in a research note published on Monday morning, MarketBeat ...

Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...

The House Revenue and Taxation Committee introduced a bill Monday that would place a massive excise tax on commercial wind ...

CIBC Asset Management Inc grew its holdings in Allison Transmission Holdings, Inc. (NYSE:ALSN – Free Report) by 5.4% during ...

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.